Stendra Avanafil Improves Erectile Function in Diabetic Men: Three-Year Clinical Trial Results

Introduction

Diabetes mellitus, a chronic condition affecting millions of American men, often leads to complications that extend beyond metabolic dysfunction, notably impacting sexual health. Among these complications, erectile dysfunction (ED) is prevalent, significantly affecting the quality of life. Recent advancements in pharmacotherapy have introduced Stendra (avanafil), a phosphodiesterase type 5 (PDE5) inhibitor, as a potential solution. This article delves into the findings of a comprehensive three-year, multi-center clinical trial exploring Stendra avanafil's efficacy and safety in improving sexual health outcomes among American men with diabetes.

Study Design and Methodology

The study, conducted across multiple centers in the United States, involved a cohort of 1,200 diabetic men aged 40-70 years, diagnosed with ED. Participants were randomly assigned to receive either Stendra avanafil or a placebo. The primary endpoint was the improvement in erectile function, assessed using the International Index of Erectile Function (IIEF) questionnaire. Secondary endpoints included patient satisfaction rates, incidence of adverse events, and changes in glycosylated hemoglobin (HbA1c) levels.

Efficacy of Stendra Avanafil

The results of the trial were compelling. Men treated with Stendra avanafil exhibited significant improvements in erectile function compared to the placebo group. The IIEF scores increased by an average of 8.2 points in the avanafil group, compared to a modest 2.1 point increase in the placebo group. This difference was statistically significant (p<0.001), underscoring Stendra's efficacy in enhancing erectile function among diabetic men.

Patient Satisfaction and Quality of Life

Beyond the clinical metrics, patient-reported outcomes were equally telling. A notable 78% of men on Stendra avanafil reported being satisfied or very satisfied with their treatment, compared to only 34% in the placebo group. This high satisfaction rate is indicative of the drug's positive impact on the overall quality of life, a critical factor for men dealing with the multifaceted challenges of diabetes.

Safety Profile and Adverse Events

The safety profile of Stendra avanafil was another highlight of the study. The incidence of adverse events was low, with the most common being mild headaches and nasal congestion, reported in 12% and 8% of the participants, respectively. Importantly, there were no significant differences in the incidence of serious adverse events between the avanafil and placebo groups, suggesting a favorable safety profile for long-term use.

Impact on Glycemic Control

An intriguing finding was the observed improvement in glycemic control among participants receiving Stendra avanafil. The mean HbA1c levels decreased by 0.4% in the avanafil group, compared to a 0.1% decrease in the placebo group. While the clinical significance of this finding requires further investigation, it suggests a potential additional benefit of Stendra avanafil in the management of diabetes.

Conclusion

The results of this multi-center clinical trial firmly establish Stendra avanafil as a highly effective and safe treatment option for American men with diabetes suffering from ED. The significant improvements in erectile function, coupled with high patient satisfaction rates and a favorable safety profile, position Stendra avanafil as a game-changer in the realm of diabetic sexual health. As we continue to explore the multifaceted impacts of diabetes, the integration of Stendra avanafil into treatment regimens offers a beacon of hope for enhancing the quality of life for millions of affected men across the United States.

Contact Us For HGH And Sermorelin Injection Treatment

Name (*)
Email (*)
Phone (*)
Select A Program (*)	HGH TherapyHGH InjectionsTestosterone InjectionsCo-Created ProgramTestosterone TherapyAt Home HRT ProgramSermorelin InjectionsIpamorelinPeptidesWeight ManagementHuman Growth HormoneShort Height TherapyGender DysmorphiaHormone TreatmentBlood PanelTesamorelinOther
Select US State (*)	U.S.A.AlabamaAlaskaArizonaArkansasCaliforniaCanadaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahU.S. Virgin IslandsVermontVirginiaWashingtonWashington,DCWest VirginiaWisconsinWyomingCanada
Select Age (30+ only)	Over 2930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475+

List of USA state clinics - click a flag below for blood testing clinics.

Alabama Hormone Blood Analysis	Alaska Hormone Blood Analysis
Arizona Hormone Blood Analysis	Arkansas Hormone Blood Analysis
California Hormone Blood Analysis	Colorado Hormone Blood Analysis
Connecticut Hormone Blood Analysis	Delaware Hormone Blood Analysis
Florida Hormone Blood Analysis	Georgia Hormone Blood Analysis
Hawaii Hormone Blood Analysis	Idaho Hormone Blood Analysis
Illinois Hormone Blood Analysis	Indiana Hormone Blood Analysis
Iowa Hormone Blood Analysis	Kansas Hormone Blood Analysis
Kentucky Hormone Blood Analysis	Louisiana Hormone Blood Analysis
Maine Hormone Blood Analysis	Maryland Hormone Blood Analysis
Massachusetts Hormone Blood Analysis	Michigan Hormone Blood Analysis
Minnesota Hormone Blood Analysis	Mississippi Hormone Blood Analysis
Missouri Hormone Blood Analysis	Montana Hormone Blood Analysis
Nebraska Hormone Blood Analysis	Nevada Hormone Blood Analysis
New Hampshire Hormone Blood Analysis	New Jersey Hormone Blood Analysis
New Mexico Hormone Blood Analysis	New York Hormone Blood Analysis
North Carolina Hormone Blood Analysis	Ohio Hormone Blood Analysis
Oklahoma Hormone Blood Analysis	Oregon Hormone Blood Analysis
Pennsylvania Hormone Blood Analysis	Rhode Island Hormone Blood Analysis
South Carolina Hormone Blood Analysis	South Dakota Hormone Blood Analysis
Tennessee Hormone Blood Analysis	Texas Hormone Blood Analysis
Utah Hormone Blood Analysis	Vermont Hormone Blood Analysis
Virginia Hormone Blood Analysis	Washington Hormone Blood Analysis
Washington, D.C. Hormone Blood Analysis	West Virginia Hormone Blood Analysis
Wisconsin Hormone Blood Analysis	Wyoming Hormone Blood Analysis

Word Count: 215